RICHARD; Isabelle

Patent Applications and Registrations

Patent applications and USPTO patent grants for RICHARD; Isabelle.The latest application filed is for "production of large-sized quasidystrophins using overlapping aav vectors".

Company Profile

3.8.17

RICHARD; Isabelle - Corbeil Essonnes FR
Richard; Isabelle - Evry FR
RICHARD; Isabelle - Corbeil FR
Richard; Isabelle - Montpellier Cedex FR
Richard; Isabelle - Corbei Essonnes FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Production Of Large-sized Quasidystrophins Using Overlapping Aav Vectors App 20220204574 - RICHARD; Isabelle ; et al.	2022-06-30
Combination treatment of sarcoglycanopathies Grant 11,298,348 - Richard , et al. April 12, 2	2022-04-12
Novel Polynucleotides Encoding A Human Fkrp Protein App 20210338837 - RICHARD; Isabelle ; et al.	2021-11-04
Methods for diagnosing or monitoring muscular dystrophies Grant 11,099,193 - Rouillon , et al. August 24, 2	2021-08-24
Hybrid Recombinant Adeno-Associated Virus Serotype Between AAV9 and AAVrh74 with Reduced Liver Tropism App 20210107948 - RICHARD; Isabelle ; et al.	2021-04-15
Combination Treatment Of Sarcoglycanopathies App 20210059999 - RICHARD; Isabelle ; et al.	2021-03-04
Selective Gene Therapy Expression System App 20180256752 - Buj Bello; Ana Maria ; et al.	2018-09-13
Selective gene therapy expression system Grant 9,981,049 - Buj Bello , et al. May 29, 2	2018-05-29
Use of epigenome-modifying compounds for the treatment of genetic muscular diseases linked to a protein-conformational disorder Grant 9,526,742 - Richard December 27, 2	2016-12-27
Methods For Diagnosing Or Monitoring Muscular Dystrophies App 20160334417 - ROUILLON; JEREMY ; et al.	2016-11-17
Selective Gene Therapy Expression System App 20160058890 - Buj Bello; Ana Maria ; et al.	2016-03-03
In Vitro Genetic Diagnostic Of Inherited Neuromuscular Disorders App 20150247196 - Soularue; Pascal ; et al.	2015-09-03
Use Of Epigenome-modifying Compounds For The Treatment Of Genetic Muscular Diseases Linked To A Protein-conformational Disorder App 20150141361 - Richard; Isabelle	2015-05-21
Drugs for the treatment of sarcogylcanopathies Grant 8,673,935 - Richard March 18, 2	2014-03-18
Calpain-3 Inhibitors For Treating Muscular Dystrophies And Cardiomyopathies App 20130171172 - Richard; Isabelle ; et al.	2013-07-04
Drugs For The Treatment Of Sarcoglycanopathies App 20130035353 - RICHARD; Isabelle	2013-02-07
Drugs for the treatment of sarcoglycanopathies Grant 8,273,763 - Richard September 25, 2	2012-09-25
Method For Predicting The Responsiveness Of A Patient To A Treatment With An Anti-cd20 Antibody And A Method For Diagnosing Rheumatoid Arthritis App 20120165208 - Apparailly; Florence ; et al.	2012-06-28
Adeno-associated Viral Vectors For The Expression Of Dysferlin App 20100266551 - Richard; Isabelle ; et al.	2010-10-21
Drugs For The Treatment Of Sarcoglycanopathies App 20100010036 - Richard; Isabelle	2010-01-14
LGMD gene coding for a calcium dependent protease Grant 6,846,623 - Beckmann , et al. January 25, 2	2005-01-25
Method for detecting calpain3 activity in a biological sample and peptides for implementing said method App 20040180395 - Richard, Isabelle ; et al.	2004-09-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.